| Autor: |
Kaniusas E; Instutute of Biomedical Electronics, Faculty of Electrical Engineering and Information Technology, Vienna University of Technology (TU Wien), Vienna, Austria., Fudim M; Division of Cardiology, Duke University Medical Center, Durham, NC, United States.; Duke Clinical Research Institute, Duke University, Durham, NC, United States., Czura CJ; Convergent Medical Technologies, Inc, New York, NY, United States., Panetsos F; Neurocomputing and Neurorobotics Research Group, Universidad Complutense de Madrid, Madrid, Spain.; Institute for Health Research (IdISSC), San Carlos Clinical Hospital, Madrid, Spain.; Silk Biomed SL, Madrid, Spain. |
| Jazyk: |
angličtina |
| Zdroj: |
Frontiers in physiology [Front Physiol] 2023 Feb 16; Vol. 14, pp. 1148819. Date of Electronic Publication: 2023 Feb 16 (Print Publication: 2023). |
| DOI: |
10.3389/fphys.2023.1148819 |
| Abstrakt: |
Competing Interests: Author CC holds equity in the company Convergent Medical Technologies, Inc., and has received financial support from Spark Biomedical, Inc., and electroCore, Inc. Author MF received financial support from the American Heart Association (20IPA35310955), Mario Family Award, Duke Chair’s Award, Translating Duke Health Award, Bayer, Bodyport, BTG Specialty Pharmaceuticals, AxonTherapies, Bodyport, Boston Scientific, CVRx, Daxor, Edwards LifeSciences, Fire1, Inovise, NXT Biomedical, Viscardia and Zoll. Author FP is shareholder of the company Silk Biomed SL. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
